JAMA Cardiology
Original Investigation
February 21, 2024
Michael T.ÌýLu, MD, MPH; Heather Ribaudo, PhD; Borek Foldyna, MD; Markella V.ÌýZanni, MD; Thomas Mayrhofer, PhD; Julia Karady, MD, PhD; Jana Taron, MD; Kathleen V.ÌýFitch, MSN; Sara McCallum, MPH; Tricia H.ÌýBurdo, PhD; Kayla Paradis, MBA; Sandeep S.ÌýHedgire, MD; Nandini M.ÌýMeyersohn, MD; Christopher DeFilippi, MD; Carlos D.ÌýMalvestutto, MD, MPH; Audra Sturniolo, MS; Marissa Diggs, BA; Sue Siminski, MBA; Gerald S.ÌýBloomfield, MD; Beverly Alston-Smith, MD; Patrice Desvigne-Nickens, MD; Edgar T.ÌýOverton, MD; Judith S.ÌýCurrier, MD; Judith A.ÌýAberg, MD; Carl J.ÌýFichtenbaum, MD; Udo Hoffmann, MD, MPH; Pamela S.ÌýDouglas, MD; Steven K.ÌýGrinspoon, MD; REPRIEVE Trial Writing Group
open access
has multimedia
JAMA Cardiol. 2024; 9(4):323-334. 10.1001/jamacardio.2023.5661
This substudy of a randomized clinical trial investigates the effects of pitavastatin on noncalcified coronary artery plaque using coronary computed tomography angiography and on inflammatory biomarkers as potential mechanisms for major adverse cardiovascular event prevention.
ÁñÁ«ÊÓƵ Network Open
Original Investigation
Cardiology
June 29, 2021
Udo Hoffmann, MD, MPH; Michael T.ÌýLu, MD, MPH; Borek Foldyna, MD; Markella V.ÌýZanni, MD; Julia Karady, MD; Jana Taron, MD; Bingxue K.ÌýZhai, MS; Tricia Burdo, PhD; Kathleen V.ÌýFitch, MSN; Emma M.ÌýKileel, MPH; Kenneth Williams, PhD; Carl J.ÌýFichtenbaum, MD; Edgar T.ÌýOverton, MD; Carlos Malvestutto, MD; Judith Aberg, MD; Judith Currier, MD; Craig A.ÌýSponseller, MD; Kathleen Melbourne, PharmD; Michelle Floris-Moore, MD; Cornelius Van Dam, MD; Michael C.ÌýKeefer, MD; Susan L.ÌýKoletar, MD; Pamela S.ÌýDouglas, MD; Heather Ribaudo, PhD; Thomas Mayrhofer, PhD; Steven K.ÌýGrinspoon, MD; REPRIEVE trial
open access
ÁñÁ«ÊÓƵ Netw Open. 2021; 4(6):e2114923. 10.1001/jamanetworkopen.2021.14923
This cohort study examines the prevalence of coronary artery disease (CAD) among adults with well-controlled HIV and low to moderate risk of atherosclerotic cardiovascular disease using computed tomography angiography and assessment of inflammation and immune activation biomarkers.
JAMA Cardiology
Brief Report
July 1, 2016
Markella V.ÌýZanni, MD; Mabel Toribio, MD; Gregory K.ÌýRobbins, MD; Tricia H.ÌýBurdo, PhD; Michael T.ÌýLu, MD; Amorina E.ÌýIshai, MD; Meghan N.ÌýFeldpausch, NP; Amanda Martin, AB; Kathy Melbourne, PharmD; Virginia A.ÌýTriant, MD, MPH; Sujit Suchindran, MD; Hang Lee, PhD; Udo Hoffmann, MD, MPH; Kenneth C.ÌýWilliams, PhD; Ahmed Tawakol, MD; Steven K.ÌýGrinspoon, MD
free access
JAMA Cardiol. 2016; 1(4):474-480. 10.1001/jamacardio.2016.0846
This study evaluates the effects of newly initiated antiretroviral therapy (ART) on arterial inflammation and other immune/inflammatory indices in ART-naive patients with human immunodeficiency virus infection.
JAMA
Preliminary Communication
July 25, 2012
Sharath Subramanian, MD; Ahmed Tawakol, MD; Tricia H. Burdo, PhD; Suhny Abbara, MD; Jeffrey Wei, BA; Jayanthi Vijayakumar, MD; Erin Corsini, BS; Amr Abdelbaky, MD; Markella V. Zanni, MD; Udo Hoffmann, MD, MPH; Kenneth C. Williams, PhD; Janet Lo, MD, MMSc; Steven K. Grinspoon, MD
free access
JAMA. 2012; 308(4):379-386. 10.1001/jama.2012.6698
Subramanian and coauthors assess arterial wall inflammation in human immunodeficiency virus using 18fluorine-2-deoxy-D-glucose positron emission tomography in relationship to traditional and nontraditional risk markers, including soluble CD163. See the related Editorial by Stein and Hsue.